C-1206

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameC-1206
Drug Alias NameC-1206
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP 90-alpha
Therapy Area/IndicationsLeukemia, Myeloid, Chronic-Phase
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFujian Medical University
China Registration ClassN/A

Develop Information

Active CompaniesFujian Medical University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Chronic-Phase
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A